MUMBAI, July 1 (Reuters) - The UK's healthcare regulator has
decided to suspended marketing approval for a widely used
antibiotic that had won clearance based on clinical trials
conducted by India's Quest Life Sciences, due to concerns over
the integrity of trial data.
Read more
No comments:
Post a Comment